Unified Patent Court (UPC) analytics are now available. Check here

EP3819007

AMGEN
Application Number
EP19208417A
Filing Date
Nov 11, 2019
Status
Granted And Under Opposition
Jun 7, 2024
Grant Date
Jul 10, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3819007B1 was granted on Jul 10, 2024 by Amgen The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSAug 2, 2024 N/A
STRAWMANJul 11, 2024 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.